Lawrence Dall

845 total citations
38 papers, 627 citations indexed

About

Lawrence Dall is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lawrence Dall has authored 38 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Epidemiology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lawrence Dall's work include Streptococcal Infections and Treatments (13 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Lawrence Dall is often cited by papers focused on Streptococcal Infections and Treatments (13 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Lawrence Dall collaborates with scholars based in United States and Puerto Rico. Lawrence Dall's co-authors include Betty Herndon, William G. Barnes, John D. Mills, John A. Stanford, Long Liang, James Stanford, Lynn Pulliam, David S. McKinsey, Joseph Brewer and Richard A. Spiegel and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Lawrence Dall

37 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Dall United States 14 316 301 190 98 95 38 627
E Gutschik Denmark 15 260 0.8× 303 1.0× 156 0.8× 116 1.2× 186 2.0× 25 658
Elisa García‐Vázquez Spain 13 315 1.0× 332 1.1× 106 0.6× 117 1.2× 67 0.7× 63 696
Joan I. Casey United States 9 269 0.9× 375 1.2× 299 1.6× 139 1.4× 152 1.6× 13 860
Paula Yocum United States 15 325 1.0× 202 0.7× 286 1.5× 83 0.8× 122 1.3× 16 725
Jeremy D. Gradon United States 15 404 1.3× 418 1.4× 227 1.2× 65 0.7× 157 1.7× 44 781
John P. Manzella United States 13 130 0.4× 264 0.9× 138 0.7× 188 1.9× 56 0.6× 24 577
Bengül Durmaz Türkiye 14 166 0.5× 142 0.5× 77 0.4× 65 0.7× 51 0.5× 42 480
Ming-Yieh Peng Taiwan 16 448 1.4× 228 0.8× 119 0.6× 85 0.9× 133 1.4× 34 820
W. R. Heizmann Germany 17 172 0.5× 233 0.8× 86 0.5× 155 1.6× 64 0.7× 57 737
Edward K. Chapnick United States 17 443 1.4× 305 1.0× 258 1.4× 148 1.5× 126 1.3× 60 875

Countries citing papers authored by Lawrence Dall

Since Specialization
Citations

This map shows the geographic impact of Lawrence Dall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Dall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Dall more than expected).

Fields of papers citing papers by Lawrence Dall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Dall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Dall. The network helps show where Lawrence Dall may publish in the future.

Co-authorship network of co-authors of Lawrence Dall

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Dall. A scholar is included among the top collaborators of Lawrence Dall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Dall. Lawrence Dall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, An‐Lin, et al.. (2021). Factors Influencing Contraceptive Use Among Sexually Active U.S. Middle and High School Students, 2015 to 2019. Cureus. 13(12). e20803–e20803. 5 indexed citations
2.
Cheng, An‐Lin, et al.. (2021). Trends in Sunscreen Use Among US Middle and High School Students, 2007-2019. Cureus. 13(7). e16468–e16468. 6 indexed citations
3.
Dall, Lawrence, et al.. (2000). Beta-blocker use in patients with acute myocardial infarction treated by hospitalists.. PubMed. 13(5). 61–3, 69. 6 indexed citations
4.
Bialkowska-Hobrzanska, Hanna, et al.. (2000). Molecular characterization and LD50 identify virulent isolates of Staphylococcus epidermidis from adult sepsis. Diagnostic Microbiology and Infectious Disease. 36(2). 75–80. 2 indexed citations
5.
Dall, Lawrence, et al.. (1998). Platelet Depletion and Severity of Streptococcal Endocarditis. Canadian Journal of Infectious Diseases and Medical Microbiology. 9(6). 359–366. 7 indexed citations
6.
Shepp, David H., C H Ramírez-Ronda, Lawrence Dall, et al.. (1997). A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 283–288. 6 indexed citations
7.
McKinsey, David S., Richard A. Spiegel, Lori Hutwagner, et al.. (1997). Prospective Study of Histoplasmosis in Patients Infected with Human Immunodeficiency Virus: Incidence, Risk Factors, and Pathophysiology. Clinical Infectious Diseases. 24(6). 1195–1203. 126 indexed citations
8.
Herndon, Betty, Lawrence Dall, & R. Padma Suvarna. (1995). Contribution of the host to test results in assays of staphylococcus epidermidis. Journal of Clinical Laboratory Analysis. 9(2). 81–88. 1 indexed citations
9.
Dall, Lawrence, et al.. (1994). Bacterial characterization in Staphylococcus epidermidis septicemia.. PubMed. 124(6). 802–7. 2 indexed citations
10.
Dall, Lawrence, Betty Herndon, & R SMITH. (1993). Reactivity of the glycocalyx of endocarditis-producing viridans group streptococci. Diagnostic Microbiology and Infectious Disease. 17(4). 259–264. 2 indexed citations
11.
Dall, Lawrence, et al.. (1993). Didanosine-induced hypertriglyceridemia. The American Journal of Medicine. 95(2). 247–247. 6 indexed citations
12.
Herndon, Betty, et al.. (1992). In vitro characteristics that predict virulence of staphylococcus epidermidis. 92. 66. 1 indexed citations
13.
Herndon, Betty, Lawrence Dall, & William G. Barnes. (1992). In vitro Assays of Staphylococcus epidermidis Characteristics and Outcome in an Endocarditis Model. Canadian Journal of Infectious Diseases and Medical Microbiology. 4(4). 203–208. 2 indexed citations
14.
Dall, Lawrence, et al.. (1990). Clindamycin Effect on Glycocalyx Production in Experimental Viridans Streptococcal Endocarditis. The Journal of Infectious Diseases. 161(6). 1221–1224. 13 indexed citations
15.
Dall, Lawrence, Long Liang, & John A. Stanford. (1989). Poncet's Disease: Tuberculous Rheumatism. Clinical Infectious Diseases. 11(1). 105–107. 46 indexed citations
16.
Dall, Lawrence & Betty Herndon. (1989). Quantitative assay of glycocalyx produced by viridans group streptococci that cause endocarditis. Journal of Clinical Microbiology. 27(9). 2039–2041. 33 indexed citations
17.
Dall, Lawrence & Gary Salzman. (1987). Treatment of Pulmonary Sporotrichosis with Ketoconazole. Clinical Infectious Diseases. 9(4). 795–798. 12 indexed citations
18.
Dall, Lawrence, et al.. (1987). Enzymatic Modification of Glycocalyx in the Treatment of Experimental Endocarditis Due to Viridans Streptococci. The Journal of Infectious Diseases. 156(5). 736–740. 43 indexed citations
19.
Dall, Lawrence, et al.. (1984). Escherichia vulneris: Isolation and Treatment. Southern Medical Journal. 77(12). 1607–1608. 4 indexed citations
20.
Dall, Lawrence, et al.. (1984). Emergence of Multidrug-Resistant Mycobacterium fortuitum during Treatment. CHEST Journal. 85(3). 440–441. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Gutschik Breakdown of academic impact, for papers by Elisa García‐Vázquez Breakdown of academic impact, for papers by Joan I. Casey Breakdown of academic impact, for papers by Paula Yocum Breakdown of academic impact, for papers by Jeremy D. Gradon Breakdown of academic impact, for papers by John P. Manzella Breakdown of academic impact, for papers by Bengül Durmaz Breakdown of academic impact, for papers by Ming-Yieh Peng Breakdown of academic impact, for papers by W. R. Heizmann Breakdown of academic impact, for papers by Edward K. Chapnick
Rankless by CCL
2026